table of content
1 Study Coverage
1.1 NSAIDs Product Introduction
1.2 Global NSAIDs Outlook 2017 VS 2022 VS 2028
1.2.1 Global NSAIDs Sales in US$ Million for the Year 2017-2028
1.2.2 Global NSAIDs Sales in Volume for the Year 2017-2028
1.3 United States NSAIDs Outlook 2017 VS 2022 VS 2028
1.3.1 United States NSAIDs Sales in US$ Million for the Year 2017-2028
1.3.2 United States NSAIDs Sales in Volume for the Year 2017-2028
1.4 NSAIDs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States NSAIDs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of NSAIDs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 NSAIDs Market Dynamics
1.5.1 NSAIDs Industry Trends
1.5.2 NSAIDs Market Drivers
1.5.3 NSAIDs Market Challenges
1.5.4 NSAIDs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 NSAIDs Market Segment by Type
2.1.1 Aspirin
2.1.2 Ibuprofen
2.1.3 Naproxen
2.1.4 Nabumetone
2.1.5 Others
2.2 Global NSAIDs Market Size by Type
2.2.1 Global NSAIDs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global NSAIDs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global NSAIDs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States NSAIDs Market Size by Type
2.3.1 United States NSAIDs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States NSAIDs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States NSAIDs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 NSAIDs Market Segment by Application
3.1.1 Back Pain Treatment
3.1.2 Osteoarthritis Treatment
3.1.3 Other Disease Treatment
3.2 Global NSAIDs Market Size by Application
3.2.1 Global NSAIDs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global NSAIDs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global NSAIDs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States NSAIDs Market Size by Application
3.3.1 United States NSAIDs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States NSAIDs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States NSAIDs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global NSAIDs Competitor Landscape by Company
4.1 Global NSAIDs Market Size by Company
4.1.1 Top Global NSAIDs Manufacturers Ranked by Revenue (2021)
4.1.2 Global NSAIDs Revenue by Manufacturer (2017-2022)
4.1.3 Global NSAIDs Sales by Manufacturer (2017-2022)
4.1.4 Global NSAIDs Price by Manufacturer (2017-2022)
4.2 Global NSAIDs Concentration Ratio (CR)
4.2.1 NSAIDs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of NSAIDs in 2021
4.2.3 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global NSAIDs Manufacturing Base Distribution, Product Type
4.3.1 Global NSAIDs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers NSAIDs Product Type
4.3.3 Date of International Manufacturers Enter into NSAIDs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States NSAIDs Market Size by Company
4.5.1 Top NSAIDs Players in United States, Ranked by Revenue (2021)
4.5.2 United States NSAIDs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States NSAIDs Sales by Players (2020, 2021 & 2022)
5 Global NSAIDs Market Size by Region
5.1 Global NSAIDs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global NSAIDs Market Size in Volume by Region (2017-2028)
5.2.1 Global NSAIDs Sales in Volume by Region: 2017-2022
5.2.2 Global NSAIDs Sales in Volume Forecast by Region (2023-2028)
5.3 Global NSAIDs Market Size in Value by Region (2017-2028)
5.3.1 Global NSAIDs Sales in Value by Region: 2017-2022
5.3.2 Global NSAIDs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America NSAIDs Market Size YoY Growth 2017-2028
6.1.2 North America NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific NSAIDs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific NSAIDs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe NSAIDs Market Size YoY Growth 2017-2028
6.3.2 Europe NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America NSAIDs Market Size YoY Growth 2017-2028
6.4.2 Latin America NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa NSAIDs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Corporation Information
7.1.2 Bayer Description and Business Overview
7.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bayer NSAIDs Products Offered
7.1.5 Bayer Recent Development
7.2 Novacap
7.2.1 Novacap Corporation Information
7.2.2 Novacap Description and Business Overview
7.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novacap NSAIDs Products Offered
7.2.5 Novacap Recent Development
7.3 Abbott
7.3.1 Abbott Corporation Information
7.3.2 Abbott Description and Business Overview
7.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Abbott NSAIDs Products Offered
7.3.5 Abbott Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer NSAIDs Products Offered
7.4.5 Pfizer Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporation Information
7.5.2 Johnson & Johnson Description and Business Overview
7.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Johnson & Johnson NSAIDs Products Offered
7.5.5 Johnson & Johnson Recent Development
7.6 Cigna
7.6.1 Cigna Corporation Information
7.6.2 Cigna Description and Business Overview
7.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Cigna NSAIDs Products Offered
7.6.5 Cigna Recent Development
7.7 Geri-Care Pharmaceuticals
7.7.1 Geri-Care Pharmaceuticals Corporation Information
7.7.2 Geri-Care Pharmaceuticals Description and Business Overview
7.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
7.7.5 Geri-Care Pharmaceuticals Recent Development
7.8 Perrigo Company
7.8.1 Perrigo Company Corporation Information
7.8.2 Perrigo Company Description and Business Overview
7.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Perrigo Company NSAIDs Products Offered
7.8.5 Perrigo Company Recent Development
7.9 Kopran
7.9.1 Kopran Corporation Information
7.9.2 Kopran Description and Business Overview
7.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Kopran NSAIDs Products Offered
7.9.5 Kopran Recent Development
7.10 Merck Sharp & Dohme
7.10.1 Merck Sharp & Dohme Corporation Information
7.10.2 Merck Sharp & Dohme Description and Business Overview
7.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Merck Sharp & Dohme NSAIDs Products Offered
7.10.5 Merck Sharp & Dohme Recent Development
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporation Information
7.11.2 Sun Pharmaceutical Industries Description and Business Overview
7.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sun Pharmaceutical Industries NSAIDs Products Offered
7.11.5 Sun Pharmaceutical Industries Recent Development
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Corporation Information
7.12.2 GlaxoSmithKline Description and Business Overview
7.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GlaxoSmithKline Products Offered
7.12.5 GlaxoSmithKline Recent Development
7.13 Reddy Pharmaceuticals
7.13.1 Reddy Pharmaceuticals Corporation Information
7.13.2 Reddy Pharmaceuticals Description and Business Overview
7.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Reddy Pharmaceuticals Products Offered
7.13.5 Reddy Pharmaceuticals Recent Development
7.14 Verywell
7.14.1 Verywell Corporation Information
7.14.2 Verywell Description and Business Overview
7.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Verywell Products Offered
7.14.5 Verywell Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 NSAIDs Industry Chain Analysis
8.2 NSAIDs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 NSAIDs Distributors
8.3 NSAIDs Production Mode & Process
8.4 NSAIDs Sales and Marketing
8.4.1 NSAIDs Sales Channels
8.4.2 NSAIDs Distributors
8.5 NSAIDs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
